Tumor suppressor p53 is a transcription factor that induces growth arrest and/or apoptosis in response to cellular stress. To identify novel p53-inducible genes, we compared the expression of genes in normal mouse embryo fibroblasts (MEFs) to p53-null cells by cDNA representational difference analysis. We report here that expression of endogenous sodium channel subunit beta 3 (SCN3B) is upregulated in mouse embryonic fibroblasts by DNA damage in a p53-dependent manner. In addition, we found that SCN3B levels are upregulated in human cancer cell lines by DNA damaging agents, as well as by overexpression of p53, but not significantly by p63 or p73. Furthermore, we identified two putative p53-binding sites upstream of the first exon (RE1) and in the third intron (RE2). The p53 protein can directly interact with the putative p53-binding sites in vivo, as assessed by chromatin immunoprecipitation. A reporter gene assay revealed that these two p53-binding sites are functional response elements. The SCN3B protein appears to be localized to the endoplasmic reticulum (ER). Introduction of the SCN3B gene into T98G and Saos2 cells potently suppressed colony formation. Furthermore, we found that adenovirus-mediated transfer of SCN3B induced apoptosis when combined with anticancer agents. The results
Introduction
Alterations of the p53 gene are among the most common and important events in human carcinogenesis (Hollstein et al., 1991) . p53 inhibits cell growth through activation of both cell cycle arrest and apoptosis, and the ability to induce apoptosis is thought to be central to its tumor-suppressor activity. p53 is induced by many types of stress, including DNA damage, oncogene activation, hypoxia, and loss of normal cell-cell contacts. It seems likely that the activation of p53-dependent apoptosis can contribute to the inhibition of cancer development at several stages during tumorigenesis.
p53 exerts various physiological functions through transactivation of downstream genes. Among the p53-inducible genes, induction of the cyclin-dependent kinase inhibitor p21 WAF1/CIP1 (hereafter referred to as p21) by p53 is central to the activation of cell cycle arrest. However, activation of p21 is not required for the induction of apoptosis. Candidates for p53-regulated apoptotic targets include mitochondrial proteins that are likely to contribute to the release of cytochrome c from the mitochondria, such as BAX (Miyashita and Reed, 1995) , NOXA (Oda et al., 2000a) , p53AIP1 (Oda et al., 2000b) , PUMA (Nakano and Vousden, 2001; Yu et al., 2001) and also proteins that play a role in death receptormediated apoptosis, such as Fas (Owen-Schaub et al., 1995) , KILLER/DR5 (Wu et al., 1997) , and PIDD (Lin et al., 2000) . To date, there does not appear to be a single gene that is the principal mediator of the p53 apoptotic signal, and it seems likely that this response represents the activation of multiple apoptosis-related genes.
Identification of novel p53-inducible genes involved in apoptosis is therefore important to better understand the physiological functions of p53. To identify target genes induced by endogenous p53 under physiological conditions, we compared gene expression in embryonic fibroblasts from normal mice to that in p53-null (p53 (À/À)) mice by cDNA representational difference analysis (RDA). We report here the identification and characterization of the sodium channel subunit beta 3 (SCN3B) as a novel p53-inducible proapoptotic gene.
Results

Scn3b expression associated with p53 activity
We used cDNA RDA to identify genes that are induced by endogenous p53. Several cDNA fragments appeared to be differentially expressed in primary mouse embryo fibroblasts (MEFs) from p53(À/À) compared to MEFs from p53( þ / þ ) mice. The results from the cDNA RDA were confirmed by semiquantitative reverse transcription-polymerase chain reaction (RT-PCR). As shown in Figure 1a , expression of known p53-inducible genes identified by RDA, such as p21, cyclin G and Annexin 8, were dependent on p53 status and were induced by adriamycin which is known to induce endogenous p53, whereas Mdm2 was not significantly induced by adriamycin in MEFs. Among the cDNA fragments identified here, we focused on one clone that was not expressed in untreated p53( þ / þ ) MEFs, but was significantly induced by adriamycin in a p53-dependent manner (Figure 1a ; Scn3b). Nucleotide sequencing followed by a database search revealed that this clone was identical to the mouse sodium channel Scn3b cDNA (Accession No. BC058636). Northern blot analysis confirmed that Scn3b expression was induced in MEFs following adriamycin treatment in a p53-dependent manner (Figure 1b) .
If the Scn3b gene has an important role downstream of p53, it would be conserved across different species. These predictions were tested in the following experiments. We tested whether Scn3b expression is induced by wild-type p53 in other rodents using REF-p53val135 containing a stably integrated murine temperaturesensitive mutant p53. RT-PCR analysis showed that expression of Scn3b mRNA was detected at 311C but not at 371C (Figure 1c) , demonstrating that the endogenous Scn3b gene is inducible in a rat embryo fibroblast cell line by murine p53 in a wild-type conformation-dependent manner.
Induction of SCN3B by p53 in human cancer cell lines
From the human genome database we found that the human SCN3B gene is composed of six exons and maps to chromosome 11q23.3. To examine whether ectopic expression of the p53 family genes could increase expression of endogenous SCN3B mRNA in human cells, human cancer cell lines were infected with each of the p53 family genes by adenovirus-mediated transfer. Replication-deficient adenoviral vectors harboring human p53 (Ad-p53), p73b (Ad-p73b), p63g (Ad-p63g) genes, and the b-galactosidase gene (Ad-lacZ) as a control were infected into human cancer cell lines. We used three human cancer cell lines, Saos2, H1299 and HCT116, that showed highly efficient gene transfer, with 90-100% of the cells staining for b-galactosidase activity at a multiplicity of infection (MOI) of 50-100 as described previously . Northern blot analysis revealed that SCN3B expression was induced by Ad-p53 in these three lines examined, especially highly in Saos2 cells (Figure 2a ). In contrast, SCN3B mRNA was not significantly increased by either Adp73b or Ad-p63g in these three cell lines (Figure 2a) . However, the more sensitive technique of semiquantitative RT-PCR revealed that SCN3B expression was increased by either Ad-p73b or Ad-p63g in Saos2 cells (data not shown).
Induction of SCN3B by DNA damage in human cancer cell lines Adenovirus-mediated transfer often employs exogenous gene expressed at levels likely to be higher than those ever encountered in vivo. To assess transcriptional induction of SCN3B at more physiological levels of p53, parental HCT116 cells with endogenous wild-type p53 and their derivative cells with targeted deletions of both p53 alleles p53(À/À) were treated with adriamycin. The induction of SCN3B was significantly detected in HCT116-p53( þ / þ ) but not in HCT116-p53(À/À) by Northern blot analysis in the condition which endogenous p53 and p21 were induced in HCT116-p53( þ / þ ) (Figure 2b ). In addition, the induction of SCN3B was detected in HCT116-p53( þ / þ ) but not in HCT116-p53(À/À) after a 24 h treatment with etoposide (data not shown). Previous studies revealed that p73 protein is increased in cells exposed to chemotherapeutic agents through transcription and protein stabilization (Agami et al., 1999; Gong et al., 1999; Yuan et al., 1999; Irwin et al., 2003; Sasaki et al., 2003) . However, we showed that the SCN3B gene is upregulated by Ad-p53 but not significantly by Ad-p73b or Semiquantitative RT-PCR analysis of Scn3b in MEFs of p53( þ / þ ) and p53(À/À) mice after treatment with 0.2 mg/ml adriamycin (ADR) for 24 h. RT-PCR analysis was performed as described in Materials and methods. We also performed semiquantitative RT-PCR analysis of known p53-target genes such as p21, cyclin G and Annexin 8. GAPDH mRNA levels were examined as a control for integrity of the cDNA. (b) Northern blot analysis shows an elevation of Scn3b and p21 mRNA levels in MEFp53( þ / þ ) exposed to 0.2 mg/ml ADR for 24 h. Ethidium bromide staining of 28S rRNA (28S) in the bottom row shows that equal amounts of RNA were loaded in each lane. (c) Semiquantitative RT-PCR analysis of rat Scn3b in REFp53val135 cells following thermoshift. These cells were incubated either at 371C (mutant-type p53 conformation) or at 311C (wild-type p53 conformation) for 16 and 24 h Ad-p63g in several human cancer cell lines (e.g., Figure 2a ). Thus, these results lend further support to the notion that SCN3B induction is regulated by endogenous p53.
p53-response elements in the SCN3B gene
To investigate whether the SCN3B gene is a direct target of transcriptional activation by p53, we searched for consensus p53-binding sequences in the human SCN3B gene. We found two potential p53-response elements, designated SCN3B-RE1 and SCN3B-RE2, (hereafter referred to as RE1 and RE2) which are located about 10 kb upstream of the first exon and in the third intron, respectively. RE1 (tGACTTGCTC tGcCTTGCCT) and RE2 (tGGCAAGgCT GAGCTAGTTC) sequences contain three-and two-mismatch nucleotides (lower letters) in noncritical positions within the 20-bp consensus p53-binding sequences, respectively (Figure 2a, El-Deiry et al., 1992) . To determine whether the p53 protein can bind directly to the RE1 and RE2 sites in vivo, we performed a chromatin immunoprecipitation (ChIP) assay using HCT116 cells infected with Ad-p53. Immunoprecipitation of DNA-protein complexes using an antibody against p53 was performed on cross-linked extract from Ad-p53-infected and control cells. We then measured the abundance of candidate response elements within the immunoprecipitated complexes by PCR amplification. The ChIP assay revealed that p53 protein resided at DNA fragments containing RE1 or RE2 ( Figure 3b , second and third rows, lanes 5 and 9). In contrast, other DNA fragments in the SCN3B promoter lacking RE1 or RE2 were amplified in the input chromatin-positive control for PCR but not in the immunoprecipitates with the anti-p53 antibody (e.g., SCN3B-PRO1 in Figure 3b , fourth row, lane 9). As expected, exogenous p53 protein resided at the p21 promoter containing a p53-response element in vivo ( Figure 3b , first row, lane 9). These ChIP assay results suggest that the exogenous p53 protein is associated with RE1 and RE2 in vivo. Finally, we demonstrated by ChIP assay that endogenous p53 protein interacts with chromatin region containing its specific binding sites RE1 and RE2 in HCT116 cells treated with adriamycin ( Figure 3b , lane 7).
To determine whether the RE1 and RE2 sequences confer p53-dependent transcriptional activity, we performed a heterologous promoter-reporter assay using a luciferase vector prepared by cloning the oligonucleotides corresponding to RE1 and RE2 upstream of a minimal promoter (see 'Materials and methods'). Control reporter plasmids pGL3-SCN3B-RE1mut and pGL3-SCN3B-RE2mut were generated by altering potentially critical nucleotides of RE1 and RE2, respectively. H1299 cells were transiently cotransfected with a reporter plasmid, together with a p53-expression or control plasmid. By comparing the ratio of luciferase activity from the wild-type-responsive sequences (RE1wt and RE2wt) to the corresponding mutantresponsive sequences (RE1mut and RE2mut), we showed that when cotransfected with p53, luciferase activities from pGL3-SCN3B-RE1wt and pGL3-SCN3B-RE2wt are 50-100-fold higher than those from pGL3-SCN3B-RE1mut and pGL3-SCN3B-RE2mut, respectively (Figure 3c ). Together, these results also support the idea that both the RE1 and RE2 sequences can mediate p53-dependent transcriptional activation, leading to the conclusion that SCN3B is a direct target of p53.
Subcellular localization of the SCN3B protein
The PSORT II program predicted the presence of potential endoplasmic reticulum (ER) targeting motifs in the SCN3B protein, suggesting that SCN3B might be an ER protein. To determine the subcellular localization of SCN3B protein, we constructed a mammalian expression vector encoding the full-length SCN3B protein with an amino-terminal FLAG epitope. We transiently transfected the plasmid into Saos2 cells and stained the cells using an anti-FLAG antibody. This immunocytochemical analysis showed that the SCN3B protein is located in the cytoplasm and plasma membrane, and the signal was strongest around the nuclear membrane, a suspected ER-Golgi zone (Figure 4, SCN3B) . To determine the subcellular 
SCN3B enhances cellular sensitivity to anticancer agents
To investigate whether SCN3B itself functions as a growth suppressor, we assayed the formation of geneticin-resistant colonies. An expression plasmid, pcDNA-SCN3B, containing the entire coding region of the human SCN3B cDNA was constructed using a mammalian expression vector pcDNA3.1( þ ), which harbors a gene conferring geneticin resistance. T98G and Saos2 cells were transfected with pcDNA-SCN3B and then grown in the presence of geneticin for 2 weeks. Figure 5 shows that introduction of the SCN3B gene resulted in substantial growth suppression, as seen by a 3-10-fold decrease in the number of geneticin-resistant colonies, though not as complete as the growth suppression observed with p53.
To investigate the proapoptotic effect of SCN3B, a recombinant adenoviral vector Ad-SCN3B expressing human SCN3B was constructed, and then Ad-SCN3B or a control Ad-lacZ vector were infected into Saos2, T98G and HCT116 cells. Flow cytometric analysis performed at 72 h after infection showed a 2-3-fold increase in sub-G1 content, which is indicative of apoptotic cells, by Ad-SCN3B relative to Ad-lacZ (Figure 6a ). SCN3B function may be an important mediator of cellular sensitivity to anticancer agents, since Scn3b is not expressed in untreated MEF-p53( þ / þ ), but is induced with adriamycin in a p53-dependent manner (Figure 1a ). To address this possibility, HCT116 cells were exposed to a low dose of anticancer agents following Ad-SCN3B infection. We observed the enhancing effect of Ad-SCN3B on adriamycin-and etoposide-induced apoptosis (Figure 6b ). In contrast, Ad-SCN3B had less effect on cisplatin-induced apoptosis. Thus, expression of the SCN3B gene induces cellular sensitivity to apoptosis by some but not all types of drugs. In HCT116 cells, Ad-p53 infection did not significantly result in apoptosis (Sasaki et al., 2001) , Figure 3 The SCN3B gene is directly transactivated by p53. (a) Human SCN3B gene structure and comparison of the two potential p53-response elements (SCN3B-RE1 and SCN3B-RE2) to the p53-consensus-binding sequence (p53CBS). Nucleotides in capital letters represent a genomic sequence identical to the consensus, whereas lowercase letters identify disparities with the consensus. The SCN3B-RE1 and SCN3B-RE2 sequences contain only threeand two-mismatched nucleotides, compared with p53CBS. R, purine; Y, pyrimidine; W, A or T. (b) ChIP assay showing that p53 protein binds to the SCN3B-RE1 and SCN3N-RE2 sites in vivo. Immunoprecipitation of DNA-protein complexes using an antibody against p53 (DO-7) was performed on cross-linked extract from untreated (no treat; lane 5), adriamycin-treated (ADR; lane 7), or Ad-p53 infected (lane 9) HCT116 cells. PCR amplification of the immunoprecipitated samples containing p21 promoter, pSCN3B-RE1, SCN3B-RE2, and SCN3B-PRO1 were performed (first to fourth rows). Input chromatin (input), which represents a portion of the sonicated chromatin before immunoprecipitation were used as positive controls (lanes 2-4) . Immunoprecipitates in the absence of antibody (Ab(À); lanes 6, 8 and 10) served as negative controls. DW, no template control (lane 1). The DNA fragment containing the SCN3B-RE1 and SCN3B-RE2 were detected in the samples immunoprecipitated with the antibody against p53 in adriamycin-treated and Ad-p53-infected HCT116 cells (lanes 7 and 9). (c) Luciferase assay for the SCN3B-RE1 and SCN3B-RE2 sequences. H1299 cells (p53 null) were cotransfected with pGL3-SCN3B-RE1, pGL3-SCN3B-RE2 or pGL3-p53CBS, together with expression vector pcDNA3.1-p53 (p53 þ ) or pcDNA3.1 (p53À). The relative luciferase activity was defined as the activity in the cells transfected with the pGL3-SCN3B-RE1wt and pGL3-SCN3B-RE2wt divided by those from the pGL3-SCN3B-RE1mut and pGL3-SCN3B-RE2mut, respectively. The histograms represent the average of three independent experiments, and error bars show the standard deviation Figure 4 Subcellular localization of the SCN3B protein. Saos2 cells were transiently transfected with SCN3B expression vector, pCMVTag2-SCN3B, containing a FLAG epitope tag. Cells were fixed and stained with antibodies to the FLAG epitope and to endogenous calnexin, an ER resident protein, followed by appropriate secondary antibodies. Transfected SCN3B (red) is colocalized with calnexin (green) in the ER. Nuclei were detected by staining cells with DAPI (blue). Original magnification, Â 1000 SCN3B is a mediator of p53-induced apoptosis K Adachi et al but had enhancing effect on cisplatin-, adriamycin-and cisplatin-induced apoptosis (Figure 6b ).
Discussion
We have shown that the induction of SCN3B by p53 is conserved across multiple species. The endogenous Scn3b gene was induced in mouse and rat embryo fibroblasts in a p53-dependent manner (Figure 1 ). In addition, endogenous SCN3B was upregulated in human cancer cells by ectopic p53 but not significantly by p73b or p63g (Figure 2a) . In response to exposure to anticancer reagents, SCN3B was induced in human cancer cells that possess wild-type p53 activity (Figure 2b ). We also identified two p53-response elements in the SCN3B gene (Figure 3 ). These results suggest that the SCN3B gene is a direct target of transcriptional activation by p53. Furthermore, transduction of SCN3B enhanced apoptosis when combined with anticancer drugs in human tumor cells (Figure 6 ), which suggests that SCN3B transfer might permit a reduction in the dose of chemotherapeutic agents and thereby minimize harmful side effects. To identify genes whose expression is regulated by p53, several approaches were previously employed.
Although a number of genes that are controlled directly by p53 have been identified, the SCN3B gene had not been identified in association with p53 induction. One reason may be that the expression level of SCN3B was still low in some types of cancer cells even after p53 overexpression (Figure 2a ). This finding supports that the response to p53 expression varies considerably among different cell types. These results also suggest one potential basis for cell-type-specific responses to p53 and for pleiotropic biological effects of p53.
The SCN3B gene encodes a polypeptide that is closely related in amino-acid sequence to the b1 subunit of a voltage-sensitive sodium channel (Morgan et al., 2000) . The voltage-sensitive sodium channel confers electrical excitability on neurons, a functional property required for higher processes including cognition. The ion-conduction a subunit of the channel is regulated by two known auxiliary subunits, b1 and b2 (Catterall, 2000) . The b1 and b2 subunits of sodium channels have similar overall structures but are not closely related in amino-acid sequence. Both b subunits are unique among ion channel subunits in that they contain a large, glycosylated extracellular domain, a single transmembrane segment, and a small intracellular domain, and appear to have dual functions -modulation of channel gating and cell-cell interaction (Isom et al., 1992 (Isom et al., , 1995 . However, little is known about the function of b3 subunit. Our immunofluorescence data suggest that the transfected SCN3B protein is mainly detected in the ER (Figure 4) , although it is possible that a small fraction of SCN3B protein is located in other cellular compartments. The subcellular localization of endogenous SCN3B protein should be examined when we obtain an anti-SCN3B antibody in the future. The results here suggest that SCN3B may be involved in a proapoptotic pathway through the ER. Recently, Bourden et al. (2002) identified Scotin, a novel p53-inducible proapoptotic protein located in the ER and the nuclear membrane, which is the first report to provide a link between p53 and the ER.
Intracellular organelles such as the mitochondria are key participants in apoptosis. However, the ER -where members of the BCL-2 family of proteins are also localized -also has been implicated in apoptosis (Scorrano et al., 2003) . Furthermore, evidence is emerging that the ER plays an important role in apoptosis (for a review see Ferri and Kroemer, 2001 ). The ER can trigger cell signals to apoptosis in response to ER stresses such as hypoxia, expression of viral proteins, inhibition of glycosylation, and disruption of calcium storage in the ER (for a review see Kaufman, 1999) . The release of calcium from the ER upon proapoptotic signaling or after drug treatment triggers the opening of the calcium-sensitive mitochondria permeability transition pore, allowing the release of cytochrome c from the mitochondria to the cytosol. Whether SCN3B is involved in promoting apoptosis in response to ER stress remains to be determined. Therefore, further studies will determine whether mutations of the SCN3B gene occur in tumors and whether SCN3B is a mediator of p53-induced apoptosis K Adachi et al the SCN3B is a bona fide tumor suppressor. In conclusion, SCN3B displays the characteristics expected as one of the genes that can contribute to p53-dependent apoptosis. The finding of SCN3B as a novel p53-inducible gene brings to light a potential role of the ER in p53-dependent apoptosis.
Materials and methods
Cell lines, cell culture and recombinant adenovirus
The human cancer cell lines used in this study were purchased from American Type Culture Collection (Manassas, VA, USA) or the Japanese Collection of Research Bioresource (Osaka, Japan). All cell lines were cultured under conditions recommended by their depositors. The status of the endogenous p53 gene in these lines is wild type for HCT116, mutant for T98G, and p53 null for Saos2 and H1299. HCT116 p53 wild type and its derivative HCT116-p53(À/À) lacking p53 were kindly provided by Dr Bert Vogelstein (Howard Hudges Medical Institute, Johns Hopkins University). MEFs from p53( þ / þ ) mice and p53(À/À) mice were provided by Dr Motoya Katsuki (National Institute for Basic Biology, Japan). A rat embryo fibroblast cell line, REF-p53val135, was established by transforming with a murine temperaturesensitive mutant p53val135 and ras . The generation and purification of replication-deficient recombinant adenoviruses containing p53, p73b, p63g genes or the bacterial LacZ gene were described previously (Ishida  et al., 2000; Sasaki et al., 2001 ).
cDNA RDA
cDNA RDA was performed according to the published procedure with RNA isolated from MEF of p53( þ / þ ) mice and from MEFs of p53(À/À) mice. The nucleotide sequences of the synthetic oligonucleotides used for the cDNA RDA were as follows: RBgl-24, 5 0 -AGCACTCTCCAGCCTCT CACCGCA-3 0 ; RBgl-12, 5 0 -GATCTGCGGTGA-3 0 ; JBgl-24, 5 0 -ACCGACGTCGACTATCCATGAACA-3 0 ; JBgl-12, 5 0 -GATCTGTTCATG-3 0 ; NBgl-24, 5 0 -AGGCAACTGTGC TATCCGAG GGAA-3 0 ; NBgl-12, 5 0 -GATCTTCCCTCG-3 0 . In all, 2 mg of double-stranded cDNA was digested with the restriction enzyme MboI, ligated to the R-Bgl-12/R-Bgl-24 adapter, and then amplified by PCR with R-Bgl-24 as a primer to generate the 'amplicon'. The adapter was removed from the 'amplicon' derived from p53(À/À) MEFs by MboI digestion, and the resulting DNA was phenol extracted and ethanol precipitated to generate the 'driver'. The 'amplicon' prepared from p53( þ / þ ) MEFs was gel purified and 2 mg was ligated to a JBgl-12/JBgl-24 adapter to generate the 'tester'. For the first subtractive hybridization, 500 ng of a JBgl-ligated tester was mixed with 40 mg of the driver and then amplified by PCR with the JBgl-24 primer, resulting in the first difference product (DP1). DP1 was PCR amplified with the JBgl-12 and JBgl-24 primers to convert both ends of the fragment to NBgl-12/ NBgl-24 adapters, and then the processes of subtractive hybridization and selective amplification (using alternately the JBgl12 and JBgl24 adapters) were repeated to generate DP2. The molar ratios of the tester and driver in the reactions producing DP2 were 1 : 400. The DP2 PCR products were cloned into the pCR4.0-T vector (Invitrogen) and sequenced. The resulting sequences were compared with the GenBank database using the BLAST search program. SCN3B is a mediator of p53-induced apoptosis K Adachi et al
Semiquantitative RT-PCR
The cDNAs for gene-specific RT-PCR were synthesized using random hexamers (Sasaki et al., 2000) . The exponential phase of the amplification was determined between 27 and 32 cycles to allow for semiquantitative comparisons among cDNAs from identical reactions. The PCR conditions involved an initial denaturation step at 941C for 1 min, followed by 32 cycles (for Scn3b) or 27 cycles (for mouse p21 and GAPDH) at 941C for 30 s -an optimal annealing temperature (601C) for each primer set -and at 721C for 45 s. Oligonucleotide primer sequences were as follows: 5 0 -CCTCCACTCTCAAT TAACTGCACACCC-3 0 (forward) and 5 0 -CCTGGTTAGC GAGTCTCAGATCTTC-3 0 (reverse) for mouse Scn3b, 5 0 -TCACTGAAGAGGCGGGAGAAG-3 0 (forward) and 5 0 -GAACAGAGTGAGGTTTAGTCCGTGTA-3 0 (reverse) for rat Scn3b, and 5 0 -ACCACAGTCCATGCCATCAC-3 0 (forward) and 5 0 -TCCACCACCCTGTTGCTGTA-3 0 (reverse) for GAPDH. The PCR products were resolved on a 3% nusieve agarose gel containing ethidium bromide.
Northern blot analysis
In all, 10 mg of total RNAs were separated by electrophoresis on a 1% agarose gel containing 2.2 M formaldehyde. The integrity and equal loading of RNA in each lane were confirmed by ethidium bromide staining of the gel. RNA was transferred onto a nitrocellulose transfer membrane (Protran; Schleicher and Schuell Inc., Keene, NH, USA) by capillary blotting in 20 Â SSC. Hybridization was performed with radiolabeled probes in 50% formamide, 5 Â Denhardt solution, 3 Â SSC, 0.1% SDS, and 100 mg/ml of salmon sperm DNA at 421C overnight. After hybridization, the membranes were washed in 1 Â SSC/0.1% SDS at room temperature, followed by washes in 0.25 Â SSC/0.1% SDS at 601C.
ChIP assay
ChIP was performed using the ChIP Assay Kit (Upstate Biotechnology) and an antibody against p53 (DO-7) as described Sasaki et al., 2002) . 2 Â 10 6 HCT116 cells were plated onto a 10-cm dish. These cells were infected with recombinant adenovirus Ad-p53 for 16 h or treated with 0.5 mg/ml of adriamycin for 24 h. Genomic DNA and protein were cross-linked by addition of formaldehyde (1% final concentration) directly to culture medium and incubated for 15 min at 371C. Cells were lysed in 200 ml of SDS lysis buffer, and sonicated to generate 300-800 bp DNA fragments. After centrifugation, the cleared supernatant was diluted 10-fold with the ChIP dilution buffer and incubated with the specific antibody at 41C for 16 h. Immune complexes were precipitated, washed, and eluted as recommended. DNAprotein cross-links were reversed by heating at 651C for 5 h, and DNA was purified and resuspended in 50 ml of TE (10 mM Tris-HCl, 1 mM EDTA). In all, 5 ml of each sample were used as a template for PCR amplification. PCR amplifications of the SCN3B gene containing the putative p53-binding sequences (RE1 and RE2 described above) were performed on immunoprecipitated chromatin using the specific primers 5 0 -ACCCAGTAGGAGGTGATTGA-3 0 (forward) and 5 0 -ACA TACCTGAGACTGGGCAA-3 0 (reverse) for RE1, and 5 0 -CTCTGGTGTGAAATGAAGGG-3 0 (forward) and 5 0 -TCCTTCTGTTTTTACCCGAG-3 0 (reverse) for RE2, respectively. PCR amplifications of SCN3B-PRO1 and p21 promoter were performed using oligonucleotides 5 0 -TAGTCCTC CAAACAGCACAG-3 0 (forward) and 5 0 -GGAAGCT TAACGCTGATATTC-3 0 (reverse) for SCN3B-PRO1, and 5 0 -ACCTTTCACCATTCCCCTAC-3 0 (forward) and 5 0 -GCCCAAGGACAAAATAGCCA-3 0 (reverse) for the p21 promoter, respectively (Shaulian et al., 2000) . To ensure that PCR was performed in the linear range of amplification, template DNA was amplified for a maximum of 32 cycles. PCR products from the ChIP assay were sequenced to verify the identity of the amplified DNA.
Luciferase assay
Reporter plasmids pGL3-SCN3B-RE1 and pGL3-SCN3B-RE2 were constructed as follows: three tandem repeats of the SCN3B-RE1wt (5 0 -TGACTTGCTCTGCCTTGCCT-3 0 ) and its mutant form SCN3B-RE1mut (5 0 -TGAATTTCTCTG CATTTCCT-3 0 ), SCN3B-RE2wt (5 0 -TGGCAAGGCT GAGCTAGTTC-3 0 ) and its mutant form SCN3B-RE2mut (5 0 -TGGAAATGCTGAGATACTTC-3 0 ) were synthesized and inserted upstream of a basal SV40 promoter in the pGL3-promoter vector (Promega), and the resulting constructs were designated pGL3-SCN3B-RE1wt, pGL3-SCN3B-RE1-mut, pGL3-SCN3B-RE2wt, and pGL3-SCN3B-RE2mut, respectively. Cultures of H1299 cells at 50% confluence in 6 cm dishes were transfected with a reporter plasmid (1.5 mg), together with 1.5 mg of a pcDNA3.1( þ ) control vector (Invitrogen) or a vector that expresses p53 (pcDNA-p53) using Lipofectin (Gibco BRL, Rockville, MD, USA) as described previously . Cells were harvested 48 h after transfection for measurement of luciferase activity using the Luciferase Assay System (Promega). The ability to stimulate transcription was defined as the ratio of luciferase activity in the cells transfected with the pGL3-SCN3B-RE1wt and pGL3-SCN3B-RE2wt relative to the activity in the cells transfected with the nonresponsive reporter plasmids pGL3-SCN3B-RE1mut and pGL3-SCN3B-RE2mut, respectively. As a control experiment, pGL3-p53CBS containing three copies of the consensus p53-binding sequence or its mutant form (Ishida et al., 2000) were transfected into H1299 cells with pcDNA-p53 or pcDNA3.1( þ ). All experiments were performed in triplicate and repeated on at least three independent occasions.
Immunofluorescence microscopy
The entire coding region of the human SCN3B cDNA was subcloned into mammalian expression vector pCMV-Tag2B (Stratagene) to place a FLAG epitope tag (DYKDDDDK) in-frame at the N-terminal of SCN3B. The plasmid construct was sequenced and named pCMVTag2-SCN3B. The construct containing the epitope tagged cDNA was transfected into Saos2 cells; 1 Â 10 4 of the cells that transiently expressed SCN3B were seeded into a four-well slide chamber (Lab-tek chamber slide, Nalge Nunc Internctiond, Naperville, IL, USA) and cultured for 24 h before immunocytochemical staining. Cells in the four-well slide chambers were fixed in cold absolute acetone for 10 min. They were then incubated for 2 h with rabbit anti-FLAG polyclonal antibody (5 mg/ml, Sigma-Aldrich) together with mouse anticalnexin monoclonal antibody (1 : 1000 dilution, BD Transduction Lab). The slides were then stained with Alexa 488-conjugated goat anti-mouse IgG and Alexa 594-conjugated goat anti-rabbit IgG (Molecular Probes) for 30 min, and counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI). After each incubation, unbound antibodies were removed by rinsing with PBS. The specimens were examined using a laser-scanning confocal microscope (Fluoview; Olympus, Japan).
